1 year return (CAGR)
14.53%
Pacific Biosciences of California Exchange (NASDAQ, USD)
PACB
1.38
-0.01 (-0.74%)
HealthcareMedical Devices
Loading...
3 year return (CAGR)
-49.48%
5 year return (CAGR)
-46.40%
10 year return (CAGR)
-16.65%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
416.51M
Price/Sales
2.62
Ent value
1.14B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.35 |
| Daily high | 1.41 |
| Daily low | 1.33 |
| Daily Volume | 5.59M |
| All-time high | 51.15 |
| 1y analyst estimate | 2.29 |
| Beta | 2.32 |
| EPS (TTM) | -0.42 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 7 May 2026 |
Downside potential
Loading...
Downside potential data
| PACB | S&P500 | |
| Current price drop from All-time high | -97.30% | -1.96% |
| Highest price drop | -98.22% | -56.47% |
| Date of highest drop | 27 May 2025 | 9 Mar 2009 |
| Avg drop from high | -70.96% | -10.68% |
| Avg time to new high | 235 days | 12 days |
| Max time to new high | 2540 days | 1805 days |
News
